OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← The Vitiligo Society

2025-03-31-accounts

VITILIGO SOCIETY EST 1985 Trustees, Annual Report and unaudited financial statements For the year ended 31 March 2025

Status: Company Limited by Guarantee No.03542195
Charity Registration No.1069607
The Company's governing document is its Memorandum and
Articles of Association dated 7 April 1998
Registered Office: 7 Bell Yard, London WC2A 2JR
The Company does not have a separate principal office.
Trustees: John Dunster (Chairperson) - appointed 27th March 2019
Natalie Ambersley - appointed 16th February 2017
Denise Oduntan - appointed 8th February 2020
Catherine Davidson - appointed 17th December 2020
Dale Biermann - appointed 20th November 2021
Alexandre Schneider - appointed 20th November 2021
Robert Symonds - appointed 26th November 2022
Rita Michaels - appointed 30th November 2023
Prof Viktoria Eleftheriadou - appointed 4th March 2025
Independent Heera Singh FMAAT
examiner: HSL Accountrancy Solutions Ltd
Enterprise House
61a Carr House Road
Doncaster
DN1 2BY
Bankers: Lloyds Bank Plc
25 Gresham Street
London
EC2V 7HN
Unity Trust Bank Plc
Nine Brindley Place
Birmingham
B1 2HB

The trustees present their report and the financial statements for the year ended 31 March 2025. This is also a Directors’ Report required by s.417 of the Companies Act 2006 and all trustees are directors.

This Trustees’ Report and the associated Financial Statements have been prepared in accordance with guidance for preparing Charity Accounts and Reports presented in “Accounting and Reporting by Charities: Statement of Recommended Practice” and are therefore in accordance with the Charities SORP (FRS 102) – Second edition October 2019 – Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) together with The Companies Act 2006.

Contents

Introduction

Introduction
Overview 4
A word from the Chairperson of The Vitiligo Society 6
The Society’s achievements and activities, from 8
1st April 2024 to 31st March 2025
Financial review 17
Financial policies 18
Independent Examiner’s report & financial statements 21
Statement of financial activities 22
Balance sheet 24
Notes to the financial statements 25

The Vitiligo Society has complied with its duty to have due regard to the guidance on public benefit published by the Charity Commission in exercising its powers or duties.

4.

Overview

Who we are

The Vitiligo Society was established in 1985 as the London Vitiligo Group and on 13 January 1986 was officially registered as a charity. The charity later changed its name to the Vitiligo Group before becoming The Vitiligo Society in 1990. The Vitiligo Society was incorporated on 7 April 1998 as a company limited by guarantee.

The Vitiligo Society is a national charity headquartered in London, and supports those living with vitiligo across the UK. As an organisation, we are proud of our long heritage and our continued commitment to improve the lives of those diagnosed with vitiligo.

Vitiligo is a long-term skin condition that causes an area of the skin to lose its colour (pigmentation), which results in the area looking white or pink in appearance. Because pigment cells give colour to hair as well as skin, some people with vitiligo may notice early onset greying of the hair or a loss of colour on the lips.

Vitiligo affects 1-2% of the world’s population. There is no prejudice in terms of who can develop the condition. Therefore, it can affect anyone, whatever their skin colour or ethnic origin, but will be more visually prominent in those with darker skin.

Vitiligo is not life-threatening and for some, embracing their new life with vitiligo is not a problem. That being said, often people find that vitiligo negatively impacts their quality of life and self-esteem. We are a charity that delivers services to support all aspects of living with vitiligo, both physically and emotionally.

5.

The Society’s mission

Our mission is to beat vitiligo by eradicating the psychological, social and physical effects on people’s lives and by finding effective treatments and a cure.

The Society’s vision

Our vision is to provide information, tools, strategies and action to help people overcome the physical, psychological and social impact that vitiligo has on their lives.

The Society’s priorities:

Our values:

6.

A word from the Chairperson of The Vitiligo Society

John Dunster, Chairperson of The Vitiligo Society

As I reflect on my final year as Chairperson of The Vitiligo Society, I feel a deep sense of pride and gratitude for all that we’ve achieved together. It has truly been a landmark year—one defined by growth, advocacy, innovation, and above all, community.

Over the past twelve months, we have continued to strengthen our position as the leading voice for people with vitiligo in the UK. We welcomed new members, expanded our digital reach to over 2.7 million people, and grew our subscriber base to more than 3,600. These are not just numbers—they represent real people who have found information, understanding, and support through our work.

One of the most powerful examples of our collective voice this year was our leadership in the campaign to reverse the initial NICE decision rejecting Ruxolitinib for non-segmental vitiligo. Through tireless advocacy and collaboration, our appeal was upheld, demonstrating the power of persistence and the importance of patient voices in shaping policy.

I’m particularly proud of our #LetsTalkVitiligo campaign, which captured national media attention and gave a platform to over 1,000 individuals who shared their stories and hopes for better treatment and support. Campaigns like this are not just milestones—they are catalysts for change.

Internally, we have strengthened our foundations with successful grant applications, new paid employees, and expanded support services including VitChat and VitSupport. From peer support to parent networks, our community-led services are now reaching more people than ever.

This year also marks the successful launch of our Local Leaders Project, building a new framework for localised, in-person support. Coupled with new resources, fundraising efforts, and our inclusive product line, we are embedding representation and empowerment at every level of our work.

As I step down from my role, I do so with full confidence in the direction of the Society. We are financially stable, strategically focused, and guided by values that reflect compassion, innovation, and inclusivity. The dedication of our trustees, volunteers, and supporters is unmatched—and I am sincerely grateful to every one of you for making my time as Chairperson so rewarding.

Thank you for trusting me to serve this extraordinary community. The journey is far from over, but I step back knowing that The Vitiligo Society is in strong and capable hands for the road ahead. I am so excited to see what the future holds and I will be cheering from the sidelines as our incredibly talented and passionate staff team, led by the incomparable Abbie Hurrell, and trustee Board lead the Society into a new era.

With heartfelt thanks, John Dunster

VITILIGO SOCIETY EST 1985

8.

The Society’s achievements and activities, from 1st April 2024 to 31st March 2025

OUR YEAR IN NUMBERS

We welcomed 50 new members, bringing our total membership to 817 and total subscribers to 3,626 S We wrote and shared 22 new lifestyle and story blogs, and 34 news, research and treatment articles Our website provided information to 146,116 users. Our education resource packs had over 1180 downloads = a

9.

OUR YEAR IN NUMBERS (Continued)

Our digital awareness activities on social media, reached over 2,720,362 people.

We answered 469 of your questions through our Live Chat Service & Contact Form, with the help of our team of Dermatologists We had over 433 people register for our support & information events We shared 10 research participation opportunities with our community We distributed 632 patient leaflets to V ~~9~~ Health Care Practitioners

10.

DELIVERING UP-TO-DATE ACCURATE INFORMATION ON VITILIGO

A key objective for our Society is to deliver up-to-date information on vitiligo to our members and followers, as well as to the medical and research community. We are UK based and the experts on vitiligo in the UK. We also recognise the part we need to play interacting with organisations around the globe, within our role as the UK vitiligo community representatives.

Maintaining up-to-date digital platforms (website)

Our website vitiligosociety.org continues to be our main hub of information, resources and signposting. We continue to update information by uploading news articles, VitLife articles and additional information pages including our new volunteer, fundraising and kids information pages.

We published 56 new articles via our VitLife blog, sharing updates, stories and lifestyle tips with our community via our newsletter and social media.

Maintaining up-to-date digital platforms (social media)

We continue to focus on growing our reach through our social media presence; this year showed great reach across all our platforms as follows:

Partnership work

We continue to work with the Global Vitiligo Foundation , BAD , NICE, Incyte UK, Pfizer UK, The National Institute of Health Clinical Research Network, Association of Francaise du Vitiligo, Eczema Outreach Support, Changing Facesand the Vitiligo International Patient Organizations Committee & Vitiligo Research Foundation.

11.

INFORMING ON AND CONTRIBUTING TO THE LATEST RESEARCH

Whilst we want to support everyone with vitiligo to feel confident in their own skin, we know that vitiligo is a health condition and we should always be striving to find a cure. This will only come from us contributing to and informing on the latest research.

Strengthening our relationships with research organisations This year saw us continue to strengthen our new relationships with Pfizer UK and Incyte UK , the National Institute for Health and Care Excellence the Scottish Medicines Consortium and the National Institute for Health Research. We also remain active members of the British Association of Dermatologists (BAD) patient support group collective.

Provide information on current and pipeline research Over the past year we shared 34 new vitiligo research study reports & news articles with our community via social media and news roundups. We recognise not only the importance of sharing reports, but also helping our community to understand the impact of research and what it means to them.

Facilitate patient and public involvement in research We continue to use our platform to identify participants for research opportunities. We found participants to support nine new research activities .

Representing Patients in NICE technology appraisals Throughout 2024–2025, The Vitiligo Society played a leading role in advocating for NHS access to Ruxolitinib (Opzelura) for the treatment of non-segmental vitiligo. Following NICE’s initial rejection of the treatment in July 2024, the Society launched a campaign to challenge the decision, culminating in a formal appeal heard in October. The appeal, supported by four other organisations, was successfully upheld in December, prompting NICE to schedule a reassessment meeting for May 2025. During this period, the Society maintained pressure through public engagement, partnerships, and direct communication with senior NHS and Government leaders, reinforcing its commitment to equitable treatment access.

12.

DEVELOPING OUR SUPPORT SERVICES

Our support service development continues to be an exciting and growing area of work for us.

Contact & voicemail service

We have an incredible volunteer team who have supported us to respond to 469 community queries about vitiligo, helping to signpost people to support services, provide tailored information and specialist feedback to questions.

Parent Support Network

The Parent Support Network continued to host online support group meeting and support via a dedicated closed facebook page. This year we increased our meetings to a monthly virtual meeting and were delighted to welcome lots of new families to our network.

The VitLife

The VitLife continues to be a source of inspiration and storytelling for our community. This year the team published 63 new articles across our news, research, story and lifestyle feature categories . We want to thank all the writers who contribute to this work. Articles are shared every month via our e-newsletter.

VitChat Service

The VitChat service continued to offer direct, one-to-one online support every Thursday evening between 7–9pm. Staffed entirely by trained volunteers, the instant messaging platform provided a confidential space where people with vitiligo could seek support, ask questions, and access signposting to relevant resources. Now in its second year, VitChat has become a valued weekly fixture, reflecting our commitment to providing accessible, peer-led emotional support to anyone affected by vitiligo.

13.

DEVELOPING OUR SUPPORT SERVICES (continued)

Peer Support

The VitSupport service provided a vital space for peer-led emotional support throughout 2024–2025. Held monthly, these virtual meetings enabled individuals affected by vitiligo to connect with others across the UK, share lived experiences, and reduce isolation. Run entirely by trained volunteers, the sessions offered a consistent opportunity for community members to find encouragement, advice, and understanding. Feedback has been overwhelmingly positive, with the team now exploring ways to develop the sessions further—potentially including guest speakers to expand their impact.

Resource Development

We continue to offer free resource packs to the vitiligo community. Last year our packs were accessed as follows:

Events calendar

Our team worked hard to develop our new Events page, and continue to build on and develop our calendar of opportunities for people to come together for support and learning. This year we hosted 19 different events , supporting 433 participants . We want to thank all the speakers and volunteers who gave their time to attend and help support our community.

We have also uploaded speaker presentations to our YouTube channel , resulting in 7 new informative videos , accessible to the public.

14.

BUILDING A STRONG VOICE FOR OUR COMMUNITY

An important part of our work is providing a voice and advocacy for our community. In order to do this we recognised that we first needed to strengthen our Society internally by reviewing our governance and building internal capacity. We also acknowledge the importance of creating a strong brand and messaging that represents our community and our voice as a united collective.

Building on our Research Work

In 2024, The Vitiligo Society launched the #LetsTalkVitiligo campaign to amplify the lived experiences of people with vitiligo and advocate for greater awareness, better access to treatment, and more inclusive support. Building on the UK’s largest ever vitiligo research survey, which involved over 1,000 participants and in-depth interviews, the campaign was delivered in two phases with support from pharmaceutical and lottery funding. Key activities included ambassador storytelling, media outreach, video content, a targeted SEO strategy, and social media advertising.

The campaign achieved national visibility through BBC 5 Live, Sky News, BBC News Online, Daily Mail Online, and more, resulting in a measurable uplift in public awareness. By March 2025, website traffic and social media reach had significantly grown, with Instagram followers surpassing 14,800 and monthly site visits peaking near 10,000. The campaign was also nominated for a 2025 Smiley Charity Film Award, validating its resonance and impact across the sector.

15.

REACHING ALL THE PEOPLE WHO NEED US

A key challenge for our Society is how we reach all the people who need us. Our transition to a digital-first organisation is the start of this journey, but there is so much more work we need to do.

Grant Application Success

On the grant-making side , we had two key successes this year:

Community Fundraising

Supporter-led fundraising remained a heartening and vital part of our income stream. Two standout campaigns included Reece, who took part in MoRunning Edinburgh in honour of his mother, raising funds while sharing a powerful story about living with vitiligo. Similarly, Linzi completed the Edinburgh Marathon 2025 after her daughter Mali’s diagnosis, helping raise awareness of the condition's long-term challenges. These stories not only generated vital income via JustGiving, but also helped build public understanding and visibility for our work. We continue to be grateful to the individuals and families who turn their personal journeys into positive action.

Online Shop

We also invested in inclusive product fundraising , launching two new Mini Vitiligo Bears to expand on the success of our original Vitiligo Bear. These soft toys, sold via our online shop, were created to support children with vitiligo and promote representation in everyday items. At £14.50 each, the bears were well received and served as both a fundraising tool and awareness-raising asset, allowing people to share stories through a comforting and symbolic product.

Growing our membership

We continue to struggle to grow our membership and recognise that the cost of living crisis impacts on the amount of money many people can donate to charities. To support financial sustainability, we also promoted monthly giving options through our digital platforms. These were positioned as affordable, low-barrier ways for supporters to make a meaningful difference.

Registration with the Fundraising Regulator

We continue to register with the UK Fundraising Regulator to ensure that donors feel confident in supporting us, and that we have the ability to protect their information and contributions to our work.

VITILIGO SOCIETY EST 1985

17.

Financial review

Total income for the year was £151,146 compared to the previous year £84,857. This increase was largely due to a number of successful grant applications.

Total expenses were £132,589 , compared to the previous year £111,730. The increase in spending represents a significant investment into raising public awareness of vitiligo, as this was highlighted as a priority from our recent community research project.

The Vitiligo Society generated a net income (termed “Net Income” in the Statement of Financial Activities) of £18,557 in 2025. This compares to a net deficit of £26,873 in 2024.

The Society’s work is entirely reliant on memberships (subscriptions) and donations from its members, together with financial support from other donors and charitable trusts. Each year the Trustees agree to a financial budget, setting out expected income together with planned expenses. This is monitored on a regular basis and the results for the year to 31 March 2025 were in line with this budget. Net Current Assets (see the Balance Sheet as at 31st March 2025) have increased to £84,860 from £66,303 in 2024. This is equivalent to more than one year’s worth of expenses at current levels. In line with previous years, the Society carries minimal liabilities and no loans/debt.

We continue to be cautious with our financial planning, balancing the requirement to demonstrate the charity’s long term financial sustainability, whilst making prudent investments into our services, community and infrastructure.

As always, we are extremely grateful to those paying membership fees (subscriptions) and also to those who feel able to provide donations, of whatever amount. All monies received are carefully managed. With this in mind, the Trustees remain ever vigilant, making sure that our operational costs are the lowest they can pragmatically be and we will continue to do this going forward.

18.

Financial policies

Grant policy

The Society occasionally awards grants to people from a variety of disciplines such as dermatology, psychology and biochemistry.

Reserves policy

The trustees believe it would be prudent to maintain the charity’s reserves to at least a sum equivalent to between six and 12 months’ operating costs, currently projected to be £64,022 - £128,045 This is in order to ensure the charity has sufficient funds in reserve to meet its statutory and contractual obligations.

Unrestricted reserves are available, at the discretion of the trustees, to further the general objects of the charity. The unrestricted funds available to the charity as at 31 March 2025 were £77,545 (£66,303 in 2024). This is considered sufficient to meet these objectives.

Managing risk of harm

The trustees carry out an annual review of the major risks to which the Society is exposed. They ensure that the systems and procedures established to manage the risks remain robust and fit for purpose. This year the Society dedicated considerable time to ensure that we comply with GDPR legislation.

Structure, governance and management

The Governing document of the Society is the Memorandum and Articles of Association. The trustees of the charity, for the purpose of charity law, are also the directors of the company for the purposes of the Companies Act.

The Society is governed by a council of management that at all times must comprise a majority of members who have vitiligo or have partners, children or siblings with the condition. One third of the members of the council retire each year and retiring members are eligible for re-election. Decisions on behalf of the charity are made by the directors, (known by the charity as trustees) who meet approximately once every three months. Trustees are appointed on recommendation by the Board of Trustees or by election at the Annual General Meeting. All new trustees are required to demonstrate a knowledge of their responsibilities and where necessary undergo training in certain areas.

19.

Going concern

The trustees are satisfied that the charity will continue to be a going concern for the foreseeable future.

Statement of Trustees' responsibilities

The trustees (who are also directors of the charitable company for the purposes of company law) are responsible for preparing the Trustees' Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure of the charitable company for that period. In preparing these financial statements, the trustees are required to:

b) observe the methods and principles in the Charities SORP;

c) make judgments and accounting estimates that are reasonable and prudent;

d) state whether applicable UK accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; e) prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.

The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report, which has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006, was approved by the Board on 21st December 2021 and signed on its behalf.

Signed:

John Dunster, Trustee/Director 5th June 2025

VITllllGO 11 1985 L,Y'FryryP,'Jryil

Vn VITILIGO SOCIETY

Independent Examiner’s Report & Financial Statements For the year ended 31 March 2025

22.

The Vitiligo Society Independent Examiners report to the Trustees (Directors) for the year ended 31st March 2025

I report on the accounts of The Vitiligo Society for the year ended 31 March 2025.

Respective responsibilities of trustees and examiner

The charity’s trustees (who are also the directors of the Company for the purposes of company law) are responsible for the preparation of the accounts. The charity’s trustees consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 (the 2011 Act) and that an independent examination is needed. The charity’s gross income exceeded £250,000 and I am qualified to undertake the examination being a full member of the AAT.

Having satisfied myself that the charity is not subject to audit under company law and is eligible for independent examination, it is my responsibility to:

Basis of independent examiner's report

My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a “true and fair view” and the report is limited to those matters set out in the statement below.

Independent examiner's statement

In connection with my examination, no matter has come to my attention:

  1. which gives me reasonable cause to believe that, in any material respect, the requirements:

  2. accounting records have not been kept in accordance with section 386 of the Companies Act 2006;

    • the accounts do not accord with such records:

  4. where accounts are prepared on an accruals basis, whether they fail to comply with relevant accounting

  5. requirements under section 396 of the Companies Act 2006, or are not consistent with the Charities SORP (FRS102)

  6. any matter which the examiner believes should be drawn to the attention of the reader to gain a proper understanding of the accounts have not been met; or to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached.

Heera Singh FMAAT HSL Accountancy Solutions Ltd Enterprise House 4-6 Thorne Doncaster DN1 2HS

Date 01/06/2025

22

23.

The Vitiligo Society

Statement of Financial Activities (Incorporating the Income and Expenditure Account) for the year ended 31st March 2025

Unrestricted Restricted Total Total
Notes Funds Funds 2025 2024
Income and endowments from: £ £ £ £
Grants and donations 2 62,138 70,059 132,197 65,372
Charitable activities
Research, information and
support 3 16,936 0 16,936 17,753
Other trading activities 4 1,707 0 1,707 1,732
Investments 5 306 0 306 0
Total 81,087 70,059 151,146 84,856
Expenditure on: 6
Raising funds 6,977 0 6,977 5,816
Charitable activities
Research, information and support 62,867 62,744 125,611 105,915
Total 69,845 62,744 132,589 111,730
Net income/(expenditure) 11,242 7,315 18,557 -26,874
Transfers between funds 0 0 0 0
Net movement in funds after transfers 11,242 7,315 18,557 -26,874
Total funds brought forward 66,303 0 66,303 93,177
Total funds carried forward 15 77,545 7,315 84,860 66,303

The Statement of Financial Activities includes all gains and losses in the year and therefore a statement of total recognised gains and losses has not been prepared. All the above amounts relate to continuing activities.

The accounting policies and notes form part of these financial statements.

23

24.

The Vitiligo Society Balance sheet As at 31st March 2025

2025 2024
Total Total
Notes £ £
Fixed Assets 0 0
Current Assets
Debtors 11 2,771 1,834
Cash at bank & in hand 130,458 113,869
133,229 115,703
Liabilities
Creditors - amounts due within one year 12 -48,369 -49,400
Net current assets Net current assets 84,860 66,303
Net assets 84,860 66,303
Funds of the company 15
Unrestricted Funds Unrestricted Funds 77,545 66,303
Restricted Funds 7,315 0
Total funds 84,860 66,303

For the year 31st March 2025 the company is entitled to the audit exemption under section 477 (2) of the Companies Act 2006.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

a) ensuring the company keeps accounting records which comply with section 386; and

b) preparing accounts which give a true and fair view of the state of affairs of the company as at the end of the financial year, and its profit or loss for the financial year, in accordance with the requirement of the companies Act 2006 relating to accounts, so far as is applicable to the company.

Small company provisions :

These accounts have been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.

The directors declare that they have approved the accounts above.

Signed on behalf of the Directors:

The accounting policies and notes form part of these financial statements.

24

25.

The Vitiligo Society Notes to the financial statements for the year ended 31st March 2025

1. Accounting policies

1.1.1. Basis of preparation

These accounts (financial statements) have been prepared under the historic cost convention, with items recognised at cost or transaction value, unless otherwise stated in the relevant note(s), in accordance with:

1.1.4. All figures presented in the statements and supporting notes have been rounded to the nearest pound.

1.2. Incoming resources

These are included in the Statement of Financial Activities. Incoming resources are recognised when, the company becomes entitled to the resources, the trustees are virtually certain they will receive the resources; and the monetary value can be measured with sufficient reliability

Where incoming resources have related expenditure (as with fund-raising or contract income) the incoming resources and related expenditure are reported gross in the Statement of Financial Activities.

Grants and donations are only included in the Statement of Financial Activities when the company has unconditional entitlement to the resources.

Contractual income is only included in the Statement of Financial Activities once the related goods or performance related services have been delivered. Investment income is included in the accounts when receivable.

1.3. Expenditure

Expenditure is charged to the Statement of Financial Activities on an accruals basis, inclusive of any VAT which cannot be recovered. Expenditure is classified under headings that aggregate all costs related to that category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Charitable expenditure comprises those costs incurred in the delivery of the charity’s activities and services for its beneficiaries, including both direct and support costs. The expenditure has been analysed but usage.

Professional fees include those costs associated with meeting constitutional and statutory requirements, including Accountancy fees.

1.4. Fund accounting

Restricted funds are funds received from donors which are subject to restrictions on the purposes for which they may be used of which have been raised for a specific project. Unrestricted funds are those where there are no externally imposed restrictions. These include funds freely available to the charity for expenditure or appropriation to reserves for internally designated purposes.

1.5. Assets

Tangible assets are capitalised if they can be used for more than one year, and cost at least £500. They are valued at cost, or, if gifted, at the value to the company on receipt.

26.

The Vitiligo Society Notes to the financial statements for the year ended 31st March 2025

1.6. Debtors

Debtors are recognised at the settlement amount due. Prepayments are valued at the amount prepaid.

1.7. Cash

Cash comprises bank deposits repayable on demand and any short-term highly liquid investments with a maturity date of three months or less from the date of acquisition or opening of the deposit or similar account.

1.8. Creditors

Creditors are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors are normally recognised at their settlement amount, usually the invoice amount.

Accrued charges are normally valued at their settlement amount.

1.9. Taxes

The company is not VAT registered. As a Charity the company is exempt from taxation on income and gains falling within section 505 of the Taxes Act 1988 or s256 of the Taxation of chargeable gains Act section 505 of the Taxes Act 1988 or s256 of the Taxation of chargeable gains Act 1992 to the extent that these are applied to its charitable objects.

2. Income from donations and legacies

General Restricted Total Total
Fund Fund 2025 2024
£ £ £ £
Donation - Members 0 0
General Donations 22,116 22,116 12,105
Grants and Donations - Trusts and Foundations 70,059 70,059 9,591
Donations in Kind 40,022 40,022 43,676
62,138 70,059 132,197 65,372
3. Income from Charitable Activities
General Restricted Total Total
Fund Fund 2025 2024
Research, Information and Support £ £ £ £
Memberships (Subscriptions) Memberships (Subscriptions) 16,936 16,936 17,753
16,936 0 16,936 17,753
4. Income from other trading activities
General Restricted Total Total
Fund Fund 2025 2024
£ £ £ £
Event income 178 178 172
Online shop sales 1,529 1,529 1,560
1,707 0 1,707 1,732
5. Income from Investments
General Restricted Total Total
Fund Fund 2025 2024
£ £ £ £
Bank interest 306 306 0

27.

The Vitiligo Society Notes to the financial statements for the year ended 31st March 2025

6. Analysis of expenditure

Cost of Charitable Support Total Total
raising funds activities costs 2025 2024
Raising funds £ £ £ £ £
Staff costs 0 20,835 11,219 32,055 24,299
Trustees expenses 0 0 403 403 635
Fundraising and publicity 5,734 41,772 0 47,506 55,534
Research support 0 37,342 0 37,342 15,165
Merchandising 1,243 0 0 1,243 480
Website and CRM 0 0 3,474 3,474 3,175
Printing, postatge and stationery 0 0 483 483 424
Office expenses 0 0 6,604 6,604 1,169
Insurance 0 0 440 440 595
Computer support and software 0 0 722 722 7,796
Phone and internet 0 0 156 156 370
Accountancy and examination 0 0 700 700 713
Legal, professional and consultancy fees 0 0 1,461 1,461 1,375
6,977 99,949 25,663 132,589 111,730
Support costs 0 25,663 -25,663 0 0
Total expenditure 2025 Total expenditure 2025 6,977 125,611 0 132,589 111,730
Total expenditure 2024 Total expenditure 2024 5,816 105,915 0 111,730

7. Trustee remuneration and expenses

Staff costs were as follows: Staff costs were as follows: Staff costs were as follows:
2025 2024
£ £
Salaries 28,813 21,777
Social security costs 440 1,648
Pension 1,441 874
Other 1,360 0
32,054 24,299

No person received emoluments of more than £60,000.in the year.

The Charity trustees were not paid or received any other benefits from employment with the charity in the year (2024 - nil). No Charity trustee received payment for professional or other services supplied to the charity (2024-nil)

8. Related party transactions

Aggregate donations from related parties during the year were Nil (2024: Nil) There are no donations from related parties which are outside the normal course of the charity’s business and no restricted donations from related parties. Some trustees donate back out of pocket expenses incurred.

28.

The Vitiligo Society Notes to the financial statements for the year ended 31st March 2025

8. Related party transactions

Aggregate donations from related parties during the year were Nil (2024- Nil) There are no donations from related parties which are outside the normal course of the charity’s business and no restricted donations from related parties. Some trustees donate back out of pocket expenses incurred.

9. Taxation

The charitable company is exempt from corporation tax as all its income is charitable and is applied for charitable purposes.

10. Fixed assets

There were no additions in respect of fixed assets during the period. Existing assets have been fully depreciated in previous accounting periods.

11. Debtors

11. Debtors
2025 2024
£ £
Trade debtors 2,604 1,514
Prepayments 167 321
2,771 1,834
12. Creditors – Due in one year Creditors – Due in one year
2025 2024
£ £
Taxation and social security 0 0
Accruals -1,769 -700
Deferred income -46,600 -48,700
13. Deferred income -48,369 -49,400
2025 2024
£ £
Balance at beginning of the year -48,700 0
Amount released to income Amount released to income 48,700 0
Amount deferred in the year Amount deferred in the year -46,600 -48,700
Balance at the end of the year -46,600 -48,700
14. Analysis of net assets between funds
General Restricted Total
Fund Fund 2025
£ £ £
Tangible fixed assets 0
Net current assets 77,545 7,315 84,860
Nets assets at 31 March 2025 77,545 7,315 84,860
General Restricted Total
Fund Fund 2024
£ £ £
Tangible fixed assets 0
Net current assets 63,184 3,119 66,303
Nets assets at 31 March 2024 63,184 3,119 66,303

29.

The Vitiligo Society Notes to the financial statements for the year ended 31st March 2025

The Vitiligo Society
Notes to the financial statements
for the year ended 31st March 2025
15.
Movement of funds
Opening Incoming Resources Closing
Balance Resources Expended Balance
Restricted funds £ £ £ £
Research 0 50,060 -50,060 0
Awards for all 0 19,999 -12,684 7,315
0 70,059 -62,744 7,315
Unrestricted funds
General funds 66,303 81,087 -69,845 77,545
Total funds 93,177 151,146 -132,589 84,860

Research funding comprised of:

Awards for all funding comprised of:

£19,999 To create and support a Local Support Group Project

16. Legal status of the Charity

The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1.